European markets close lower as investors await inflation data; Zealand Pharma up 35%

This was CNBC's live blog covering European markets.

European markets closed lower on Monday, as global investors looked ahead to more inflation data out this week.

The Stoxx 600 index closed the session 0.4% lower after ending last week at a record high. Sectors were broadly negative, with mining down 2.1% and utilities 1.2% lower.

In stock movements, Denmark's Zealand Pharma soared 35% to an all-time high after reporting strong trial results from a drug with uses in the booming weight-loss market.

The monthly personal consumption expenditures price index, the U.S Federal Reserve's favored inflation gauge, is due out Thursday.

U.S. markets were little changed on Monday as investors looked forward to the latest inflation reading as well as a slew of big earnings reports this week.

Overnight in Asia-Pacific markets, Japan's Nikkei 225 index hit a fresh high Monday as traders returned from a long weekend, while measures by South Korean authorities to boost its stock markets did little to push up the main index.

U.S. stocks started Monday's trading session little changed.

The Dow Jones Industrial Average ticked down 5 points, or 0.01%.

The S&P 500 and Nasdaq Composite added 0.07% and 0.28%, respectively.

— Hakyung Kim

Marc Allera, CEO of BT Consumer, discusses the company's plans with EE, its 5G strategy and the future of cellphones.

Shares in meal delivery service Hellofresh were 10% lower in early afternoon trade, at the bottom of the Stoxx 600 index, after UBS slashed its target price on the stock.

The bank's analysts highlighted risks to its 2024 guidance ahead of full-year results due next month, and a challenging U.S. market.

— Jenni Reid

Shares of Denmark's Zealand Pharma were up 32% at 11 a.m. London time after the company